ReviewAnnals of surgical oncology2022
Malignant Bowel Obstruction Management Over Time: Are We Doing Anything New? A Current Narrative Review.
Review in Annals of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 31 citations in OpenAlex.
- ASO Author Reflections: Cohesive Multidisciplinary Care in Malignant Bowel Obstruction-A Necessary Paradigm Shift.Annals of surgical oncology · 2026Article
- Exploring Pathways to Optimise Care in malignant bowel obstruction (EPOC): A realist review of shared decision-making with people with advanced cancer and severe symptoms.Palliative medicine · 2026Review
- Quality of Life Following Palliative Surgery for Malignant Bowel Obstruction: A Scoping Review.Journal of surgical oncology · 2026Article
- Impact of treatment strategy after malignant bowel obstruction in stage IV gastrointestinal cancer: population-based cohort study.BJS open · 2025Article
- Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025Article
- Contemporary Management of Malignant Bowel Obstruction.Clinics in colon and rectal surgery · 2025Review
- Global burden of paralytic ileus and intestinal obstruction, 1990-2021: a GBD 2021 analysis.Journal of health, population, and nutrition · 2025Article
- Small bowel obstruction due to intra-abdominal hernia: New thoughts on diagnosis and treatment.World journal of clinical cases · 2025Article
- Difficulties and Disparities in Colorectal Cancer End-of-Life Care: A Patient's Story.Clinics in colon and rectal surgery · 2025Review
- Gastro-Intestinal Symptoms in Palliative Care Patients.Current oncology (Toronto, Ont.) · 2024Review
- Malignant Bowel Obstruction: A Retrospective Multicenter Cohort Study.Journal of clinical medicine · 2024Article
- Article
- Enhanced gastric decompression for palliation of malignant bowel obstruction.Surgical endoscopy · 2023Article
- Sustained delivery of PARP inhibitor Talazoparib for the treatment ofFrontiers in oncology · 2023Article
- Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges.International journal of women's health · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMalignant bowel obstruction from peritoneal carcinomatosis affects a significant proportion of luminal gastrointestinal and ovarian oncology patients, and portends poor long-term survival. The management approach for these patients includes a range of medical therapies and surgical options; however, how to select an optimal treatment strategy remains enigmatic. The goal of this narrative review was to summarize the latest evidence around multimodal malignant bowel obstruction treatment and to establish if and where progress has been made.
methodsA targeted literature search examining articles focused on the management of malignant bowel obstruction from peritoneal carcinomatosis was performed. Following data extraction, a narrative review approach was selected to describe evidence and guidelines for surgical prognostic factors, imaging, tube decompression, medical management, nutrition, and quality of life.
resultsOutcomes in the literature to date are summarized for various malignant bowel obstruction treatment strategies, including surgical and non-surgical approaches, as well as a discussion of the role of total parenteral nutrition and chemotherapy in holistic malignant bowel obstruction management.
conclusionThere has been little change in survival outcomes in malignant bowel obstruction in over more than a decade and there remains a paucity of high-level evidence to direct treatment decision making. Healthcare providers treating patients with malignant bowel obstruction should work to establish consensus guidelines, where feasible, to support medical providers in ensuring compassionate care during this often terminal event for this unique patient group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.